# Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin

> **NCT02811055** · PHASE2 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 5 (actual)

## Conditions studied

- Type 2 Diabetes
- Hypertension

## Interventions

- **BIOLOGICAL:** Blood sampling
- **PROCEDURE:** Blood Pressure Measurement
- **DEVICE:** electrocardiogram
- **PROCEDURE:** orthostatic test
- **DRUG:** Administration of Aprepitant
- **DRUG:** Administration of placebo

## Key facts

- **NCT ID:** NCT02811055
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-13
- **Primary completion:** 2020-12-05
- **Final completion:** 2020-12-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811055, "Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02811055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*